,outcome,arm 1,arm 2
0,intervention,PF tafluprost,PF timolol patients
0,"pruritus, ocular pain/stinging/irritation","2.5%, 4.4%",1.5%
0,ocular pain/stinging/irritation,NR,4.6%
